News
The benefits of 52-week biologic therapy on asthma control and lung function are observed in both never smokers and ...
Opinion
2hOpinion
Zacks Investment Research on MSN3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff ThreatsGeneric drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...
3h
Zacks Investment Research on MSNAcquisitions, Licensing Deals Take Centerstage in Pharma/Biotech SpaceMergers and Acquisitions (M&A) have picked up significant pace in 2025 in the pharma/biotech sector after a passive run in 2024. The recent spree of acquisitions signifies a focus on portfolio ...
Atopic dermatitis manifests differently in patients with darker skin color, according to the companies, including subtler presentations and more severe and prolonged lesions compared to patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results